Kumondai Masaki 公文代將希

Researcher Number	30908778
Other IDs
Affiliation (Current)	2025: 東北大学, 大学病院, 助教
Affiliation (based on the past Project Information) *help	2022 – 2024: 東北大学, 大学病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 47060:Clinical pharmacy-related
Keywords	Principal Investigator バイオマーカー / 薬剤性肝障害 / TDM / LC-MS/MS / CYP3A4 / CYP3A

Research Projects
(2 results)
Research Products
(7 results)

薬剤性肝障害早期発見バイオマーカーの探索と有用性評価Principal Investigator
- Principal Investigator
  
  公文代將希
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Tohoku University
Development of Drug Administration Design Method Utilizing Urinary Biomarkers for Predicting CYP3A4 ActivityPrincipal Investigator
- Principal Investigator
  
  Kumondai Masaki
- Project Period (FY)
  2022 – 2023
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Tohoku University

All 2024 2023 2022

All Journal Article Presentation

[Journal Article] Plasma venetoclax concentrations in patients with acute myeloid leukemia treated with CYP3A4 inhibitors2024
- Author(s)
  Ayaka Otsuki, Masaki Kumondai, Daisuke Kobayashi, Masafumi Kikuchi, Yugo Ueki, Yuji Sato, Nagomi Hayashi, Ayaka Yagi, Yasushi Onishi, Koichi Onodera, Satoshi Ichikawa, Noriko Fukuhara, Hisayuki Yokoyama, Masamitsu Maekawa, Nariyasu Mano
- Journal Title
  
  Yakugaku Zasshi
  
  Volume: 7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K15333
[Journal Article] Therapeutic Drug Monitoring of Blood Sirolimus and Tacrolimus Concentrations for Polypharmacy Management in a Lymphangioleiomyomatosis Patient Taking Two Cytochrome P450 3A Inhibitors2023
- Author(s)
  Kumondai Masaki、Kikuchi Masafumi、Mizuguchi Atsushi、Hayashi Nagomi、Ui Masahiro、Hirama Takashi、Okada Yoshinori、Sato Yu、Sato Toshihiro、Maekawa Masamitsu、Mano Nariyasu
- Journal Title
  
  Tohoku J. Exp. Med.
  
  Volume: 260 Issue: 1 Pages: 29-34
- DOI
  10.1620/tjem.2023.J016
- ISSN
  0040-8727, 1349-3329
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08509, KAKENHI-PROJECT-21K06708, KAKENHI-PROJECT-22K15333
[Journal Article] Development of a Simultaneous Liquid Chromatography-Tandem Mass Spectrometry Analytical Method for Urinary Endogenous Substrates and Metabolites for Predicting Cytochrome P450 3A4 Activity2023
- Author(s)
  Masaki Kumondai, Masamitsu Maekawa, Eiji Hishinuma, Yu Sato, Toshihiro Sato, Masafumi Kikuchi, Masahiro Hiratsuka, Nariyasu Mano
- Journal Title
  
  Biological and Pharmaceutical Bulletin
  
  Volume: 46 Issue: 3 Pages: 455-463
- DOI
  10.1248/bpb.b22-00840
- ISSN
  0918-6158, 1347-5215
- Year and Date
  2023-03-01
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06708, KAKENHI-PROJECT-22K15333
[Presentation] 薬物投与量設計におけるCYP活性予測バイオマーカー測定の有用性の検証2023
- Author(s)
  公文代將希, 前川正充, 眞野成康
- Organizer
  第33回日本医療薬学会年会
- Invited
- Data Source
  KAKENHI-PROJECT-22K15333
[Presentation] 肺移植患者における複数のCYP3A阻害薬とシロリムスおよびタクロリムスの相互作用を考慮した投与量設計2023
- Author(s)
  公文代將希, 菊地正史, 水口敦史, 林和未, 宇井雅博, 平間崇, 岡田克典, 佐藤裕, 佐藤紀宏, 前川正充, 眞野成康
- Organizer
  日本病院薬剤師会東北ブロック第12回学術大会
- Data Source
  KAKENHI-PROJECT-22K15333
[Presentation] 薬物代謝酵素活性の尿中内因性バイオマーカー測定法の構築と血中薬物濃度との相関解析による有用性の検討2022
- Author(s)
  公文代將希, 前川正充, 眞野成康
- Organizer
  第62回日本臨床化学会年次学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-22K15333
[Presentation] 尿中内因性CYP3A4活性バイオマーカーの一斉定量系構築と臨床応用2022
- Author(s)
  公文代將希, 前川正充, 菊地正史, 小川玲佳, 岩崎瑞生, 押切華映, 齋藤明博, 二宮匡史, 井上淳, 佐藤真実, 中島範昭, 眞野成康
- Organizer
  第96回日本薬理学会年会 / 第43回日本臨床薬理学会学術総会
- Data Source
  KAKENHI-PROJECT-22K15333

Kumondai Masaki 公文代 將希

Research Projects

Research Products

薬剤性肝障害早期発見バイオマーカーの探索と有用性評価Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of Drug Administration Design Method Utilizing Urinary Biomarkers for Predicting CYP3A4 ActivityPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Plasma venetoclax concentrations in patients with acute myeloid leukemia treated with CYP3A4 inhibitors2024

Author(s)

Journal Title

Data Source

[Journal Article] Therapeutic Drug Monitoring of Blood Sirolimus and Tacrolimus Concentrations for Polypharmacy Management in a Lymphangioleiomyomatosis Patient Taking Two Cytochrome P450 3A Inhibitors2023

Author(s)

Journal Title

DOI

ISSN

Language

Data Source

[Journal Article] Development of a Simultaneous Liquid Chromatography-Tandem Mass Spectrometry Analytical Method for Urinary Endogenous Substrates and Metabolites for Predicting Cytochrome P450 3A4 Activity2023

Author(s)

Journal Title

DOI

ISSN

Year and Date

Language

Data Source

[Presentation] 薬物投与量設計におけるCYP活性予測バイオマーカー測定の有用性の検証2023

Author(s)

Organizer

Data Source

[Presentation] 肺移植患者における複数のCYP3A阻害薬とシロリムスおよびタクロリムスの相互作用を考慮した投与量設計2023

Author(s)

Organizer

Data Source

[Presentation] 薬物代謝酵素活性の尿中内因性バイオマーカー測定法の構築と 血中薬物濃度との相関解析による有用性の検討2022

Author(s)

Organizer

Data Source

[Presentation] 尿中内因性CYP3A4活性バイオマーカーの一斉定量系構築と臨床応用2022

Author(s)

Organizer

Data Source

Kumondai Masaki 公文代將希

[Presentation] 薬物代謝酵素活性の尿中内因性バイオマーカー測定法の構築と血中薬物濃度との相関解析による有用性の検討2022